    {"id":102400,"date":"2023-08-02T08:42:20","date_gmt":"2023-08-02T06:42:20","guid":{"rendered":"https:\/\/investmentbell.com\/?p=102400"},"modified":"2023-08-07T13:01:26","modified_gmt":"2023-08-07T11:01:26","slug":"haleon-raises-annual-organic-revenue-growth-forecast-on-steady-demand","status":"publish","type":"post","link":"https:\/\/investmentbell.com\/ms\/news\/market-overview\/haleon-raises-annual-organic-revenue-growth-forecast-on-steady-demand\/","title":{"rendered":"Haleon menaikkan ramalan pertumbuhan hasil organik tahunan atas permintaan yang stabil"},"content":{"rendered":"<p>(Reuters) &#8211; Haleon on Wednesday raised its forecast for annual organic revenue growth as the consumer healthcare company is confident that demand for its oral and respiratory health products will stick despite a cost-of-living squeeze.<\/p>\n\n\n\n<p>Consumers prioritising money towards essential, daily-use products amid the cost-of-living crisis in some parts of the world boosted sales for companies such as Haleon, which spun off from British drugmaker GSK last year.<\/p>\n\n\n\n<p>U.S.-based rival Kenvue, the former consumer health unit of Johnson &amp; Johnson (NYSE:JNJ), forecast full-year profit above market estimates in July.<\/p>\n\n\n\n<p>Haleon, the world&#8217;s largest standalone consumer healthcare firm, said its full-year organic revenue growth is now expected to come in at 7-8%, compared with an earlier forecast of the top-end of a 4-6% range. Analysts on average expect growth of 6.2%, according to company-compiled estimates.<\/p>\n\n\n\n<p>Haleon&#8217;s organic revenue growth for the six-month period ended June 30 was 10.4%, beating analysts&#8217; expectations of 8.2%.<\/p>\n<div class=\"rate-now\"><span id=\"rate-mypost102400\"><\/span> <span id=\"rate-points\"> 0<\/span><\/div>\n\t\t\t<script type=\"text\/javascript\">jQuery('#rate-mypost102400').raty({\n\t\t\t\thalfShow : true,\n\t\t\t\thalf: true,readOnly: true,score: 0,\n\t\t\t\tpath: \"https:\/\/investmentbell.com\/wp-content\/plugins\/userpro-rating\/images\/\"\n\t\t\t\t});<\/script>","protected":false},"excerpt":{"rendered":"<p>(Reuters) &#8211; Haleon on Wednesday raised its forecast for annual organic revenue growth as the consumer healthcare company is confident that demand for its oral and respiratory health products will stick despite a cost-of-living squeeze. Consumers prioritising money towards essential, daily-use products amid the cost-of-living crisis in some parts of the world boosted sales for [&hellip;]<\/p>","protected":false},"author":13,"featured_media":102413,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[89],"tags":[],"class_list":{"0":"post-102400","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-market-overview-news"},"_links":{"self":[{"href":"https:\/\/investmentbell.com\/ms\/wp-json\/wp\/v2\/posts\/102400","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/investmentbell.com\/ms\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/investmentbell.com\/ms\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/investmentbell.com\/ms\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/investmentbell.com\/ms\/wp-json\/wp\/v2\/comments?post=102400"}],"version-history":[{"count":0,"href":"https:\/\/investmentbell.com\/ms\/wp-json\/wp\/v2\/posts\/102400\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/investmentbell.com\/ms\/wp-json\/wp\/v2\/media\/102413"}],"wp:attachment":[{"href":"https:\/\/investmentbell.com\/ms\/wp-json\/wp\/v2\/media?parent=102400"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/investmentbell.com\/ms\/wp-json\/wp\/v2\/categories?post=102400"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/investmentbell.com\/ms\/wp-json\/wp\/v2\/tags?post=102400"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}